Cargando…

Insights into Pathogenesis, Nutritional and Drug Approach in Sarcopenia: A Systematic Review

Sarcopenia is a multifactorial condition related to the loss of muscle mass and strength due to aging, eating habits, physical inactivity, or even caused by another disease. Affected individuals have a higher risk of falls and may be associated with heart disease, respiratory diseases, cognitive imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Mellen, Rodrigo Haber, Girotto, Otávio Simões, Marques, Eduarda Boni, Laurindo, Lucas Fornari, Grippa, Paulo Cesar, Mendes, Claudemir Gregório, Garcia, Lorena Natalino Haber, Bechara, Marcelo Dib, Barbalho, Sandra Maria, Sinatora, Renata Vargas, Haber, Jesselina Francisco dos Santos, Flato, Uri Adrian P., Bueno, Patricia Cincotto dos Santos, Detregiachi, Claudia Rucco Penteado, Quesada, Karina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856128/
https://www.ncbi.nlm.nih.gov/pubmed/36672642
http://dx.doi.org/10.3390/biomedicines11010136
Descripción
Sumario:Sarcopenia is a multifactorial condition related to the loss of muscle mass and strength due to aging, eating habits, physical inactivity, or even caused by another disease. Affected individuals have a higher risk of falls and may be associated with heart disease, respiratory diseases, cognitive impairment, and consequently an increased risk of hospitalization, in addition to causing an economic impact due to the high cost of care during the stay in hospitals. The standardization of appropriate treatment for patients with sarcopenia that could help reduce pathology-related morbidity is necessary. For these reasons, this study aimed to perform a systematic review of the role of nutrition and drugs that could ameliorate the health and quality of life of sarcopenic patients and PRISMA guidelines were followed. Lifestyle interventions have shown a profound impact on sarcopenia treatment but using supplements and different drugs can also impact skeletal muscle maintenance. Creatine, leucine, branched-chain amino acids, omega 3, and vitamin D can show benefits. Although with controversial results, medications such as Metformin, GLP-1, losartan, statin, growth hormone, and dipeptidyl peptidase 4 inhibitors have also been considered and can alter the sarcopenic’s metabolic parameters, protect against cardiovascular diseases and outcomes, while protecting muscles.